Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evogene Ltd Ord (NQ: EVGN )

0.5700 -0.0200 (-3.39%)
Streaming Delayed Price Updated: 3:57 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 49,673
Open 0.5900
Bid (Size) 0.5600 (11)
Ask (Size) 0.5700 (6)
Prev. Close 0.5900
Today's Range 0.5600 - 0.6100
52wk Range 0.5502 - 1.300
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS
Tryp Therapeutics, Inc. (OTCQB: TRYPF) (CSE:TRYP) has submitted an Investigational New Drug application to the U.S. 
Via Benzinga
Evogene Q1 Revenue Grows 170% YoY, Here Are The Details
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in... 
Via Benzinga

Performance

YTD
-21.38%
-21.38%
1 Month
-11.21%
-11.21%
3 Month
-14.93%
-14.93%
6 Month
-13.77%
-13.77%
1 Year
-37.53%
-37.53%

More News

Read More
Evogene: Q1 Earnings Insights
Via Benzinga
Earnings Scheduled For May 18, 2023
Via Benzinga
Evogene's Earnings Outlook
Via Benzinga
Evogene 2022 Revenue Grows 80% To 1.7M
Via Benzinga
Evogene's Earnings Outlook
Via Benzinga
Preview: Evogene's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
Via Benzinga
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Via Talk Markets
Evogene Offers An Excellent Risk/Reward Ratio
Via Talk Markets
Canonic Launches Six Second-Generation Cannabis Products With Higher THC And Rich Terpene Profiles
Via Benzinga
Evogene Q3 Revenue Grows 208% YoY, Here Are The Details
Via Benzinga
Earnings Scheduled For November 17, 2022
Via Benzinga
Canonic Launches Its High THC Medical Cannabis Products In Israel
Via Benzinga
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
Via Benzinga
Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know
Via Benzinga
Earnings Scheduled For August 31, 2022
Via Benzinga
Earnings Outlook For Evogene
Via Benzinga
ADDING MULTIMEDIA ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
From ICL Group LTD
Via Business Wire
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
Via Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Via Benzinga
Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt?
Via Benzinga
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Earnings Scheduled For May 26, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.